Cargando…
Post-COVID-19 Cholestasis: A Case Series and Review of Literature
BACKGROUND: Coronavirus disease-2019 (COVID-19) cholangiopathy is a recently known entity. There are very few reports of liver transplantation (LT) for COVID-19-induced cholangiopathy. It is well known that vaccines can prevent severe disease and improve outcomes. However, there are no reports on th...
Autores principales: | Kulkarni, Anand V., Khelgi, Amit, Sekaran, Anuradha, Reddy, Raghuram, Sharma, Mithun, Tirumalle, Sowmya, Gora, Baqar A., Somireddy, Arjun, Reddy, Jignesh, Menon, Balachandran, Reddy, Duvvur N., Rao, Nagaraja P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187855/ https://www.ncbi.nlm.nih.gov/pubmed/35719861 http://dx.doi.org/10.1016/j.jceh.2022.06.004 |
Ejemplares similares
-
Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure
por: Kulkarni, Anand V., et al.
Publicado: (2023) -
Postliver Transplantation Rhino-Orbital Mucormycosis, an Unexpected Cause of a Downhill Course
por: Sabhapandit, Swapnali, et al.
Publicado: (2022) -
Patients with decompensated cirrhosis and liver transplant recipients demonstrate poor humoral and cellular immune response against COVID-19 vaccine
por: Kulkarni, Anand, et al.
Publicado: (2022) -
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients
por: Kulkarni, Anand V., et al.
Publicado: (2022) -
COVID-19 vaccine induced autoimmune hepatitis-a first case series from India
por: Iyengar, Sowmya, et al.
Publicado: (2022)